colorectal adenocarcinoma
colorectal adenocarcinoma
Explore linked clinical trials. Standard reference: MONDO:000500841 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Performance and Safety of MiWEndo-assisted Colonoscopy (MiWEndo II) | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, colonic disorder, colorectal adenocarcinoma, colorectal adenoma, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, disease, intestinal disorder, neoplasm, polyp of large intestine, rectal disorder | Recruiting | Not applicable | 2026-10-08 | NCT05988645 | |
| Family Communications After Genetic Testing | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colon adenocarcinoma, colonic disorder, colonic neoplasm, colorectal adenocarcinoma, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder, rectal neoplasm, rectum adenocarcinoma | Recruiting | Not applicable | 2026-10-02 | NCT07143487 | |
| TLR9 Immunotherapy for Peritoneal Carcinomatosis | Abdominal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Peritoneal Diseases, adenocarcinoma, appendix adenocarcinoma, carcinoma, colorectal adenocarcinoma, cystic, mucinous, and serous neoplasm, epithelial neoplasm, mucinous adenocarcinoma, neoplasm, peritoneal neoplasm | Recruiting | Phase 1 | 2026-10-01 | NCT07658196 | |
| Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal adenocarcinoma, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 2 | 2026-09-29 | NCT07551596 | |
| A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, colorectal adenocarcinoma, metastatic neoplasm, neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2026-09-29 | NCT05731271 | |
| Exploratory Evaluation of the BiP Inhibitor BPR001-615 in Primary Cells and the Diagnostic Value of Circulating BiP in Colorectal Adenocarcinomas | colorectal adenocarcinoma | Recruiting | Not applicable | 2026-09-17 | NCT07813884 | |
| A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors | Head and Neck Neoplasms, Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, cervical adenocarcinoma, colorectal adenocarcinoma, head and neck cancer, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 1 | 2026-09-17 | NCT07020117 | |
| A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum | Colorectal Neoplasms, Hereditary Nonpolyposis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA repair disease, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Nutritional and Metabolic Diseases, colonic disorder, colorectal adenocarcinoma, colorectal neoplasm, digestive system disorder, digestive system neoplasm, hereditary disease, hereditary neoplastic syndrome, intestinal disorder, metabolic disease, neoplasm | Recruiting | Phase 2 | 2026-09-16 | NCT07811193 | |
| Breath Research Narrow Validation for Gastrointestinal Cancer Detection | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, cholangiocarcinoma, colonic disorder, colorectal adenocarcinoma, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, epithelial neoplasm, esophageal adenocarcinoma, esophageal disorder, esophageal squamous cell carcinoma, gastric adenocarcinoma, gastric neoplasm, hepatocellular carcinoma, intestinal disorder, liver disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, rectal disorder, squamous cell carcinoma, squamous cell neoplasm, stomach disorder | Recruiting | Not stated | 2026-09-11 | NCT07714538 | |
| Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas | Ewing sarcoma, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, colorectal adenocarcinoma, connective tissue neoplasm, neoplasm, osteosarcoma, sarcoma | Recruiting | Phase 1 | 2026-09-08 | NCT03715933 | |
| Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B) | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, adenocarcinoma, appendix adenocarcinoma, carcinoma, carcinoma of esophagus, colorectal adenocarcinoma, cystic, mucinous, and serous neoplasm, digestive system disorder, digestive system neoplasm, disease, epithelial neoplasm, esophageal disorder, gastric neoplasm, mucinous adenocarcinoma, neoplasm, small intestine adenocarcinoma, stomach disorder | Recruiting | Phase 2 | 2026-08-31 | NCT07795749 | |
| Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer | colorectal adenocarcinoma | Recruiting | Phase 1 | 2026-08-20 | NCT06225011 | |
| A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for High-Grade Appendiceal and Colorectal Adenocarcinoma With Peritoneal Metastasis | Appendiceal Cancer, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, appendiceal neoplasm, cecal disorder, cecal neoplasm, colorectal adenocarcinoma, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm | Recruiting | Not applicable | 2026-07-21 | NCT07291180 | |
| Chemotherapy and/or Metastasectomy in Treating Patients With Metastatic Colorectal Adenocarcinoma With Lung Metastases | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal adenocarcinoma, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Active, not recruiting | Phase 2 | 2026-07-16 | NCT03599752 | |
| Serplulimab Plus Decitabine and CAPOX Before Surgery for Locally Advanced Colorectal Cancer | colorectal adenocarcinoma | Not yet recruiting | Phase 2 | 2026-07-09 | NCT07691632 | |
| Early Detection of Advanced Adenomas and Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colonic neoplasm, colorectal adenocarcinoma, colorectal cancer, colorectal neoplasm, colorectal serrated adenocarcinoma, digestive system disorder, digestive system neoplasm, hereditary mixed polyposis syndrome, intestinal disorder, neoplasm, polyp of large intestine, rectal disorder | Recruiting | Not stated | 2026-07-07 | NCT06342440 | |
| Early Onset Colorectal Cancer Detection | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colonic neoplasm, colorectal adenocarcinoma, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder, rectal neoplasm | Recruiting | Not stated | 2026-07-07 | NCT06342401 | |
| Stage II/III Colorectal Cancer Recurrence | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal adenocarcinoma, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Not stated | 2026-07-07 | NCT06314958 | |
| Evaluation of Skin Tests in Biotherapy Allergies | B-cell chronic lymphocytic leukemia, Chronic Disease, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Esophageal Neoplasms, Head and Neck Neoplasms, Hemic and Lymphatic Diseases, Immunoglobulin Light-chain Amyloidosis, Leukemia, B-Cell, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, adenocarcinoma, adenoma, amyloidosis, bronchial neoplasm, bronchogenic carcinoma, carcinoma, cardiovascular disorder, cholangiocarcinoma, colonic disorder, colorectal adenocarcinoma, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal disorder, esophageal squamous cell carcinoma, follicular lymphoma, heart cancer, heart disorder, hematologic disorder, hepatocellular carcinoma, immune system disorder, immunoproliferative disorder, intestinal disorder, leukemia, liver disorder, lung disorder, lung neoplasm, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, malignant mesothelioma, mesothelial neoplasm, mesothelioma, metabolic disease, monoclonal gammopathy, neoplasm, plasma cell neoplasm, pleural mesothelioma, pleural neoplasm, proteostasis deficiencies, rectal disorder, respiratory system disorder, respiratory tract neoplasm, squamous cell carcinoma, squamous cell neoplasm | Recruiting | Not applicable | 2026-06-18 | NCT06971848 | |
| A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression | Adnexal Diseases, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, adenoma, bronchial neoplasm, bronchogenic carcinoma, cancer, colonic disorder, colonic neoplasm, colorectal adenocarcinoma, colorectal cancer, colorectal carcinoma, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, intestinal disorder, lung cancer, lung disorder, lung neoplasm, malignant colon neoplasm, malignant endocrine neoplasm, malignant mesothelioma, malignant pancreatic neoplasm, mesothelial neoplasm, mesothelioma, neoplasm, non-small cell lung carcinoma, non-small cell squamous lung carcinoma, ovarian cancer, ovarian disorder, pancreas disorder, pancreatic neoplasm, pleural neoplasm, rectal cancer, rectal disorder, rectal neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-06-12 | NCT06051695 | |
| Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal adenocarcinoma, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Not stated | 2026-05-29 | NCT04739072 | |
| Measurement of MMP-14 Protein, a Potential New Marker for Colorectal Cancer Detection, in Plasma Vesicles Named Exosomes | colorectal adenocarcinoma | Recruiting | Not applicable | 2026-04-09 | NCT06955767 | |
| Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colon adenocarcinoma, colonic disorder, colonic neoplasm, colorectal adenocarcinoma, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, malignant colon neoplasm, neoplasm, rectal cancer, rectal disorder, rectal neoplasm, rectum adenocarcinoma | Active, not recruiting | Phase 2 | 2026-03-31 | NCT04963283 | |
| Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases | Abdominal Neoplasms, Body Temperature Changes, Digestive System Diseases, Digestive System Neoplasms, Heat Stress Disorders, Hyperthermia, Neoplasms by Site, Pathological Conditions, Signs and Symptoms, Peritoneal Diseases, Signs and Symptoms, colonic disorder, colonic neoplasm, colorectal adenocarcinoma, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, injury, intestinal disorder, neoplasm, peritoneal neoplasm, peritoneum cancer, rectal disorder | Active, not recruiting | Phase 2 / Phase 3 | 2026-03-24 | NCT02758951 | |
| AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer | colorectal adenocarcinoma | Recruiting | Phase 3 | 2026-03-04 | NCT06951503 |